熱門資訊> 正文
PharmaCorp Rx Inc.报告第二季度业绩
2025-08-19 01:59
- PharmaCorp Rx Inc. press release (TSXV:PCRX:CA): Q2 Net loss for the quarter reflects continued investment in corporate infrastructure and the catch-up of executive compensation deferred from 2024
- Operating infrastructure was successfully deployed to support national scalability, including systems integration, pharmacy onboarding, and co-ownership execution
- A strong balance sheet positions the Corporation to fund additional acquisitions already under letter of intent
More on PharmaCorp Rx Inc.
- Financial information for PharmaCorp Rx Inc.
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
